420 related articles for article (PubMed ID: 2562982)
21. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.
Schultz KR; Klarnet JP; Gieni RS; HayGlass KT; Greenberg PD
Science; 1990 Aug; 249(4971):921-3. PubMed ID: 2118273
[TBL] [Abstract][Full Text] [Related]
22. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
23. Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.
Milan G; Zambon A; Cavinato M; Zanovello P; Rosato A; Collavo D
J Virol; 1999 Mar; 73(3):2280-7. PubMed ID: 9971811
[TBL] [Abstract][Full Text] [Related]
24. Immunogenic determinants of a neuropathogenic murine leukemia virus.
Robbins DS; Remington MP; Sarzotti M; St Louis D; Hoffman PM
J Virol; 1995 Nov; 69(11):6847-51. PubMed ID: 7474098
[TBL] [Abstract][Full Text] [Related]
25. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
26. Resistance to cellular immune response in AKR leukemias.
Schäfer A; Schmidt W
Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
[TBL] [Abstract][Full Text] [Related]
27. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
Browning MJ; Huang AS; Reiss CS
J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
[TBL] [Abstract][Full Text] [Related]
28. Major and minor Kb-restricted epitopes encoded by the endogenous ecotropic murine leukemia virus AKR623 that are recognized by anti-AKR/Gross MuLV CTL.
White HD; Roeder DA; Lam T; Green WR
Viral Immunol; 1994; 7(2):51-9. PubMed ID: 7848510
[TBL] [Abstract][Full Text] [Related]
29. Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells.
Rich RF; Green WR
J Virol; 1999 May; 73(5):3826-34. PubMed ID: 10196277
[TBL] [Abstract][Full Text] [Related]
30. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
Manjunath R; Graziano RF; Green WR
J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
[TBL] [Abstract][Full Text] [Related]
31. Molecular definition of retrovirus-induced antigens recognized by tumour-specific H-2-restricted cytolytic T lymphocytes.
Plata F; Langlade-Demoyen P; Abastado JP; Berbar T; Kourilsky P
J Immunogenet; 1986; 13(2-3):263-8. PubMed ID: 3493297
[TBL] [Abstract][Full Text] [Related]
32. Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses.
Kent SJ; Stallard V; Corey L; Hu SL; Morton WR; Gritz L; Panicali DL; Greenberg PD
AIDS Res Hum Retroviruses; 1994 May; 10(5):551-60. PubMed ID: 7917517
[TBL] [Abstract][Full Text] [Related]
33. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
[TBL] [Abstract][Full Text] [Related]
34. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus.
Chesebro B; Britt W; Evans L; Wehrly K; Nishio J; Cloyd M
Virology; 1983 May; 127(1):134-48. PubMed ID: 6305011
[TBL] [Abstract][Full Text] [Related]
35. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
36. Differing T-cell requirements for recombinant retrovirus vaccines.
Hasenkrug KJ; Brooks DM; Nishio J; Chesebro B
J Virol; 1996 Jan; 70(1):368-72. PubMed ID: 8523549
[TBL] [Abstract][Full Text] [Related]
37. Immune suppression of vaccine-induced CD8
Podschwadt P; Malyshkina A; Windmann S; Papadamakis A; Kerkmann L; Lapuente D; Tenbusch M; Lu M; Schindler M; Lang KS; Hansen W; Bayer W
Front Immunol; 2022; 13():934399. PubMed ID: 36605206
[TBL] [Abstract][Full Text] [Related]
38. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
Kundu SK; Merigan TC
AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446
[TBL] [Abstract][Full Text] [Related]
39. Subgenomic fragment of molecular cloned Friend murine leukemia virus DNA contains the gene(s) responsible for Friend murine leukemia virus-induced disease.
Oliff A; Linemeyer D; Ruscetti S; Lowe R; Lowy DR; Scolnick E
J Virol; 1980 Sep; 35(3):924-36. PubMed ID: 6252347
[TBL] [Abstract][Full Text] [Related]
40. Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).
Nihrane A; Silver J
Immunology; 1997 Feb; 90(2):219-28. PubMed ID: 9135550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
